Search Results 191-200 of 18965 for creatine

1. Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL - Mayo Clinic

   Creatinine ≤ 1.5 x institutional ULN or Creatinine Clearance > 30 ml/min. Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral ...

2. Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer - Mayo Clinic

   ... creatinine ≤ 1.5 x ULN; Within 2 weeks prior to randomization, there must be postoperative evidence of adequate renal function; urine protein/creatinine ...

3. Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma - Mayo Clinic

   Creatinine clearance or radioisotope GFR ≥ 70 mL/min OR maximum serum creatinine based on age/gender as follows. 0.4 mg/dL (1 to 5 months); 0.5 mg/dL (6 ...

4. Phase I Study of LB-100 With Docetaxel in Solid Tumors - Mayo Clinic

   Patients must have adequate renal function, defined as serum creatinine ≤ 1.2 mg/dL (if > 1.2 mg/dL, a calculated creatinine clearance [Cockcroft-Gault method] ...

5. A Study of Cediranib and Olaparib Combined, Compared to Either Drug Alone, or to a Standard Chemotherapy in Treating Patients who have a Return of Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

   Creatinine =< 1.5 x the institutional ULN; Urine protein: creatinine ratio urine protein creatinine (UPC) of =< 1 OR less than or equal to 2+ proteinuria on ...

6. SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab - Mayo Clinic

   Creatinine ≤ 1.5 mg/dL;; AST/ALT ≤ 2.5 X ULN for subject with no liver metastases;; ≤ 5 X ULN for subjects with liver metastases;; Bilirubin ≤ 1.5 mg/dL ...

7. Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy - Mayo Clinic

   Creatinine ≤ 1.5 mg/dL OR creatinine clearance ≥ 30 mL/min/1.73 m2 for patients with creatinine levels above 1.5 mg/dL; UPC < 1 or, if UPC ≥ 1, 24-hour ...

8. A Study of Grapiprant and Pembrolizumab in Patients with Advanced or Progressive MSS Colorectal Cancer - Mayo Clinic

   Serum creatinine ≤1.5 × upper limit of normal (ULN) or creatinine clearance ≥ 40 mL/min for patients with creatinine levels >1.5 × institutional ULN ...

9. Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer - Mayo Clinic

   Have adequate renal function as defined by the following criteria: Creatinine ≤ 1.5 x ULN and CrCl ≥ 30 ml/min per Cockcroft Gault formula: Have adequate ...

10. Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye - Mayo Clinic

    Serum creatinine ≤ 1.5 × ULN, OR calculated creatinine clearance ≥ 30 mL/minute (modified Cockroft and Gault formula); Hemoglobin ≥ 9 g/dL; Serum albumin ...